Compounds > plerixafor
Page last updated: 2024-08-24

plerixafor and Bile Duct Cancer

plerixafor has been researched along with Bile Duct Cancer in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (40.00)29.6817
2010's2 (40.00)24.3611
2020's1 (20.00)2.80

Authors

AuthorsStudies
Bian, W; Liu, JH; Liu, SG; Lv, HT; Wang, WB; Xing, L; Zhang, TF1
Li, J; Mott, JL; Oupický, D; Wang, Y; Wehrkamp, CJ; Xie, Y1
Caligiuri, A; Galastri, S; Gentilini, A; Invernizzi, P; Mantero, S; Marra, F; Mello, T; Mingarelli, E; Pinzani, M; Rombouts, K; Roncalli, M1
Harada, K; Ishikawa, A; Isse, K; Kozaka, K; Nakanuma, Y; Nimura, Y; Oda, K; Ohira, S; Sasaki, M; Sato, Y; Zen, Y1
Hongeng, S; Leelawat, K; Leelawat, S; Narong, S1

Other Studies

5 other study(ies) available for plerixafor and Bile Duct Cancer

ArticleYear
The effect of gemcitabine combined with AMD3100 applying to cholangiocarcinoma RBE cell lines to CXCR4/CXCL12 axis.
    Scandinavian journal of gastroenterology, 2021, Volume: 56, Issue:8

    Topics: Benzylamines; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Cell Line, Tumor; Cell Movement; Cell Proliferation; Chemokine CXCL12; Cholangiocarcinoma; Cyclams; Deoxycytidine; Gemcitabine; Humans; Neoplasm Invasiveness; Receptors, CXCR4

2021
Delivery of miR-200c Mimic with Poly(amido amine) CXCR4 Antagonists for Combined Inhibition of Cholangiocarcinoma Cell Invasiveness.
    Molecular pharmaceutics, 2016, Mar-07, Volume: 13, Issue:3

    Topics: Apoptosis; Benzylamines; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Blotting, Western; Cell Movement; Cell Proliferation; Cholangiocarcinoma; Cyclams; Drug Delivery Systems; Drug Therapy, Combination; Heterocyclic Compounds; Humans; MicroRNAs; Neoplasm Invasiveness; Polyamines; Real-Time Polymerase Chain Reaction; Receptors, CXCR4; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Tumor Cells, Cultured

2016
Role of the stromal-derived factor-1 (SDF-1)-CXCR4 axis in the interaction between hepatic stellate cells and cholangiocarcinoma.
    Journal of hepatology, 2012, Volume: 57, Issue:4

    Topics: Adult; Aged; Apoptosis; Benzylamines; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Cell Communication; Cell Line, Tumor; Chemokine CXCL12; Chemotaxis; Cholangiocarcinoma; Cyclams; Female; Gene Silencing; Hepatic Stellate Cells; Heterocyclic Compounds; Humans; Liver; Macrophage Migration-Inhibitory Factors; Male; MAP Kinase Signaling System; Middle Aged; Phosphatidylinositol 3-Kinases; Phosphorylation; Primary Cell Culture; Receptors, CXCR4; RNA

2012
Possible regulation of migration of intrahepatic cholangiocarcinoma cells by interaction of CXCR4 expressed in carcinoma cells with tumor necrosis factor-alpha and stromal-derived factor-1 released in stroma.
    The American journal of pathology, 2006, Volume: 168, Issue:4

    Topics: Aged; Aged, 80 and over; Antigens, CD; Antigens, Differentiation, Myelomonocytic; Benzylamines; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Cell Line; Cell Line, Tumor; Cell Movement; Cell Proliferation; Chemokine CXCL12; Chemokines, CXC; Cholangiocarcinoma; Cyclams; Female; Fibroblasts; Heterocyclic Compounds; Humans; Liver; Macrophages; Male; Middle Aged; Neoplasm Invasiveness; Receptors, CXCR4; Stromal Cells; Tumor Necrosis Factor-alpha

2006
Roles of the MEK1/2 and AKT pathways in CXCL12/CXCR4 induced cholangiocarcinoma cell invasion.
    World journal of gastroenterology, 2007, Mar-14, Volume: 13, Issue:10

    Topics: Benzylamines; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Butadienes; Cell Line, Tumor; Chemokine CXCL12; Chemokines, CXC; Cholangiocarcinoma; Chromones; Cyclams; Cytoskeleton; Enzyme Inhibitors; Gene Expression Regulation, Neoplastic; Heterocyclic Compounds; Humans; MAP Kinase Kinase 1; MAP Kinase Kinase 2; Morpholines; Neoplasm Invasiveness; Nitriles; Oncogene Protein v-akt; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Receptors, CXCR4; Signal Transduction

2007